Publikationen

Zeitschriftenartikel

• Wagner, Ferdinand; König, Stefanie; Wuermeling, Quirin Johannes; Sitzberger, Alexandra; Paolini, Marco; Weigert, Annabelle; Lauseker, Michael; Endres, Felix; Schneller, Julia; Hubertus, Jochen; Holzapfel, Boris Michael; Birkenmaier, Christof; Ziegler, Christian Max (2024)
  Ultrasound supports clinical decision-making in determining the Sanders’ skeletal maturity score of the hand
  In: International Orthopaedics, Vol. 48: S. 1971-1978 (Volltext vorhanden)
  
• Brioli, Annamaria; Lomaia, Elza; Fabisch, Christian; Sacha, Tomasz; Klamova, Hana; Morozova, Elena; Golos, Aleksandra; Ernst, Philipp; Olsson-Stromberg, Ulla; Zackova, Daniela; Nicolini, Franck E.; Bao, Han; Castagnetti, Fausto; Patkowska, Elzbieta; Mayer, Jiri; Hirschbühl, Klaus; Podgornik, Helena; Paczkowska, Edyta; Parry, Anne; Ernst, Thomas; Voskanyan, Astghik; Szczepanek, Elzbieta; Saussele, Susanne; Franke, Georg-Nikolaus; Kiani, Alexander; Faber, Edgar; Krause, Stefan; Casado, Luis Felipe; Lewandowski, Krzysztof; Eder, Matthias; Anhut, Peter; Gil, Justyna; Südhoff, Thomas; Hebart, Holger; Heibl, Sonja; Pfirrmann, Markus; Hochhaus, Andreas; Lauseker, Michael (2024)
  Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry
  In: Leukemia, Vol. 38: S. 1072-1080 (Volltext vorhanden)
  
• Hehlmann, Rüdiger; Lauseker, Michael (2024)
  How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapies
  In: Leukemia, Vol. 38, Nr. 2: S. 465-466 (Volltext vorhanden)
  
• Delazer, Luisa; Bao, Han; Lauseker, Michael; Stauner, Livia; Nübling, Georg; Conrad, Julian; Noachtar, Soheyl; Havla, Joachim; Kaufmann, Elisabeth (2024)
  Association between retinal thickness and disease characteristics in adult epilepsy: a cross‐sectional OCT evaluation
  In: Epilepsia Open, Vol. 9, Nr. 1: S. 236-249 (Volltext vorhanden)
  
• Schulz, Felicitas; Hauch, Ulrich; Ketzler-Henkel, Sandra; Heyde, Eyck von der; Koenigsmann, Michael; Lauseker, Michael; Schulte, Nora; Germing, Ulrich (2023)
  Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR
  In: Journal of Clinical Medicine, Vol. 12, Nr. 20 (Volltext vorhanden)
  
• Spinell, Thomas; Kröger, Annika; Freitag, Lena; Würfl, Gregor; Lauseker, Michael; Hickel, Reinhard; Kebschull, Moritz (2023)
  Dental implant material related changes in molecular signatures in peri-implantitis – A systematic review of omics in-vivo studies
  In: Dental Materials, Vol. 39, Nr. 12: S. 1150-1158
  
• Lauseker, Michael; Hehlmann, Rüdiger; Hochhaus, Andreas; Saußele, Susanne (2023)
  Survival with chronic myeloid leukaemia after failing milestones
  In: Leukemia, Vol. 37: S. 2231-2236 (Volltext vorhanden)
  
• Silzle, Tobias; Blum, Sabine; Kasprzak, Annika; Nachtkamp, Kathrin; Rudelius, Martina; Hildebrandt, Barbara; Götze, Katharina S.; Gattermann, Norbert; Lauseker, Michael; Germing, Ulrich (2023)
  The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score
  In: Cancers, Vol. 15, Nr. 14 (Volltext vorhanden)
  
• Siller, Sebastian; Kunz, Mathias; Lauseker, Michael; Dimitriadis, Konstantinos; Dorn, Franziska; Tonn, Joerg-Christian; Schichor, Christian (2023)
  The impact of initial counselling for patients’ decision-making and the accuracy of interdisciplinary neurovascular board evaluation in elective treatment of unruptured intracranial aneurysms - a German single-centre retrospective study
  In: Clinical Neurology and Neurosurgery, Vol. 232
  
• Freitag, Lena; Spinell, Thomas; Kröger, Annika; Würfl, Gregor; Lauseker, Michael; Hickel, Reinhard; Kebschull, Moritz (2023)
  Dental implant material related changes in molecular signatures in peri-implantitis. A systematic review and integrative analysis of omics in-vitro studies
  In: Dental Materials, Vol. 39, Nr. 1: S. 101-113
  
• Kirchner, Sophie-Kathrin; Lauseker, Michael; Adorjan, Kristina; Anderson-Schmidt, Heike; Anghelescu, Ion-George; Baune, Bernhardt T.; Budde, Monika; Dannlowski, Udo; Dietrich, Detlef E.; Fallgatter, Andreas J.; Falkai, Peter; Figge, Christian; Gade, Katrin; Heilbronner, Urs; Hiendl, Lena; Juckel, Georg; Kalman, Janos L.; Klöhn-Saghatolislam, Farahnaz; Konrad, Carsten; Lang, Fabian U.; Oraki Kohshour, Mojtaba; Papiol, Sergi; Reich-Erkelenz, Daniela; Reimer, Jens; Reininghaus, Eva Z.; Schaupp, Sabrina K.; Schmauß, Max; Schmitt, Andrea; Schulte, Eva Christina; Senner, Simon; Spitzer, Carsten; Vogl, Thomas; Zimmermann, Jörg; Hasan, Alkomiet; Schulze, Thomas G.; Senner, Fanny (2022)
  Medication Adherence in a Cross-Diagnostic Sample of Patients From the Affective-to-Psychotic Spectrum: Results From the PsyCourse Study
  In: Frontiers in Psychiatry, Vol. 12 (Volltext vorhanden)
  
• Wang, Katharina; Schütze, Ina; Gulde, Sebastian; Bechmann, Nicole; Richter, Susan; Helm, Jana; Lauseker, Michael; Maurer, Julian; Reul, Astrid; Spoettl, Gerald; Klink, Barbara; William, Doreen; Knösel, Thomas; Friemel, Juliane; Bihl, Michel; Weber, Achim; Fankhauser, Maria; Schober, Laura; Vetter, Diana; Broglie Däppen, Martina; Ziegler, Christian G; Ullrich, Martin; Pietzsch, Jens; Bornstein, Stefan R; Lottspeich, Christian; Kroiss, Matthias; Fassnacht, Martin; Wenter, Vera Ursula Julia; Ladurner, Roland; Hantel, Constanze; Reincke, Martin; Eisenhofer, Graeme; Grossman, Ashley B; Pacak, Karel; Beuschlein, Felix; Auernhammer, Christoph J; Pellegata, Natalia S; Nölting, Svenja (2022)
  Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures
  In: Endocrine-Related Cancer, Vol. 29, Nr. 6: S. 285-306
  
• Hehlmann, Rüdiger; Lauseker, Michael; Voskanyan, Astghik; Fabarius, Alice; Haferlach, Claudia; Hochhaus, Andreas; Saußele, Susanne (2022)
  Impact of emerging ACA on survival in chronic myeloid leukemia (CML)
  In: Leukemia, Vol. 36: S. 2544-2547 (Volltext vorhanden)
  
• Rautenberg, Christina; Stölzel, Friedrich; Germing, Ulrich; Schroeder, Thomas; Middeke, Jan Moritz; Lauseker, Michael (2021)
  Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
  In: Blood Cancer Journal, Vol. 11, Nr. 10 (Volltext vorhanden)
  
• Strapatsas, Judith; Barbulescu, Elena Calina; Lauseker, Michael; Kaivers, Jennifer; Hildebrandt, Barbara; Nachtkamp, Kathrin; Strupp, Corinna; Rudelius, Martina; Haas, Rainer; Germing, Ulrich (2021)
  Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients
  In: Annals of Hematology, Vol. 100: S. 2575-2584 (Volltext vorhanden)
  
• Siller, Sebastian; Lauseker, Michael; Karschnia, Philipp; Niyazi, Maximilian; Eigenbrod, Sabina; Giese, Armin; Tonn, Joerg-Christian (2021)
  The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents
  In: Acta neuropathologica communications, Vol. 9, Nr. 1: S. 35 (Volltext vorhanden)
  
• Kaufmann, Elisabeth; Hordt, Mirjam; Lauseker, Michael; Palm, Ulrich; Noachtar, Soheyl (2021)
  Acute effects of spaced cathodal transcranial direct current stimulation in drug resistant focal epilepsies
  In: Clinical Neurophysiology, Vol. 132, Nr. 7: S. 1444-1451
  
• Rautenberg, Christina; Lauseker, Michael; Kaivers, Jennifer; Jäger, Paul; Fischermanns, Carolin; Pechtel, Sabrina; Haas, Rainer; Kobbe, Guido; Germing, Ulrich; Schroeder, Thomas (2021)
  Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDS
  In: European Journal of Haematology (Volltext vorhanden)
  
• Schüttler, Dominik; Hamm, Wolfgang; Krammer, Simone; Steffen, Julius; Deuster, Eileen; Lauseker, Michael; Egger, Florian; Meyer, Tim; Brunner, Stefan (2021)
  Staying on the ball during COVID-19 pandemic: impact on training modalities in football players
  In: The Journal of Sports Medicine and Physical Fitness 2021, Vol. 62, Nr. 5: S. 595-601
  
• Siller, Sebastian; Lauseker, Michael; Karschnia, Philipp; Niyazi, Maximilian; Eigenbrod, Sabina; Giese, Armin; Tonn, Joerg-Christian (2021)
  The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents
  In: Acta Neuropathologica Communications, Vol. 9, Nr. 35 (Volltext vorhanden)
  
• Rautenberg, Christina; Germing, Ulrich; Stepanow, Stefanie; Lauseker, Michael; Köhrer, Paul S.; Geyh, Stefanie; Fan, Min; Haas, Rainer; Kobbe, Guido; Schroeder, Thomas (2021)
  Influence of somatic mutations and pretransplant strategies in patients allografted for myelodysplastic syndrome or secondary acute myeloid leukemia
  In: American Journal of Hematology, Vol. 96, Nr. 1 (Volltext vorhanden)
  
• Egeli, Damla Buket; Hanfstein, Benjamin; Lauseker, Michael; Pfirrmann, Markus; Saussele, Susanne; Baerlocher, Gabriela M.; Müller, Martin C. (2021)
  SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment
  In: Leukemia & Lymphoma: S. 1-8
  
• Egeli, Damla Buket; Hanfstein, Benjamin; Lauseker, Michael; Pfirrmann, Markus; Saussele, Susanne; Baerlocher, Gabriela M.; Müller, Martin C. (2021)
  SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment
  In: Leukemia & Lymphoma, Vol. 63, Nr. 4: S. 955-962
  
• Kaufmann, Elisabeth; Hordt, Mirjam; Lauseker, Michael; Palm, Ulrich; Noachtar, Soheyl (2021)
  Acute effects of spaced cathodal transcranial direct current stimulation in drug resistant focal epilepsies
  In: Clinical Neurophysiology, Vol. 132, Nr. 7: S. 1444-1451
  
• Rautenberg, Christina; Lauseker, Michael; Kaivers, Jennifer; Jäger, Paul; Fischermanns, Carolin; Pechtel, Sabrina; Haas, Rainer; Kobbe, Guido; Germing, Ulrich; Schroeder, Thomas (2021)
  Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDS
  In: European Journal of Haematology, Vol. 107, Nr. 2: S. 283-292
  
• Rautenberg, Christina; Stoelzel, Friedrich; Roellig, Christoph; Stelljes, Matthias; Gaidzik, Verena; Lauseker, Michael; Kriege, Oliver; Verbeek, Mareike; Unglaub, Julia Marie; Thol, Felicitas; Krause, Stefan W.; Haenel, Mathias; Neuerburg, Charlotte; Vucinic, Vladan; Jehn, Christian-Friedrich; Severmann, Julia; Wass, Maxi; Fransecky, Lars; Chemnitz, Jens; Holtick, Udo; Schaefer-Eckart, Kerstin; Schroeder, Josephine; Kraus, Sabrina; Krueger, William; Kaiser, Ulrich; Scholl, Sebastian; Koch, Kathrin; Henning, Lea; Kobbe, Guido; Haas, Rainer; Alakel, Nael; Roehnert, Maximilian-Alexander; Sockel, Katja; Hanoun, Maher; Platzbecker, Uwe; Holderried, Tobias A. W.; Morgner, Anke; Heuser, Michael; Sauer, Tim; Goetze, Katharina S.; Wagner-Drouet, Eva; Doehner, Konstanze; Doehner, Hartmut; Schliemann, Christoph; Schetelig, Johannes; Bornhaeuser, Martin; Germing, Ulrich; Schroeder, Thomas; Middeke, Jan Moritz (2021)
  Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
  In: Blood Cancer Journal, Vol. 11, Nr. 10
  
• Siller, Sebastian; Lauseker, Michael; Karschnia, Philipp; Niyazi, Maximilian; Eigenbrod, Sabina; Giese, Armin; Tonn, Jörg-Christian (2021)
  The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents
  In: Acta Neuropathologica Communications, Vol. 9, Nr. 1
  
• Strapatsas, Judith; Barbulescu, Elena Calina; Lauseker, Michael; Kaivers, Jennifer; Hildebrandt, Barbara; Nachtkamp, Kathrin; Strupp, Corinna; Rudelius, Martina; Haas, Rainer; Germing, Ulrich (2021)
  Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients
  In: Annals of Hematology, Vol. 100, Nr. 10: S. 2575-2584
  
• Leuschner, Gabriela; Lauseker, Michael; Howanietz, Anne-Sophie; Milger, Katrin; Veit, Tobias; Munker, Dieter; Schneider, Christian; Weig, Thomas; Michel, Sebastian; Barton, Jürgen; Meiser, Bruno; Dinkel, Julien; Neurohr, Claus; Behr, Jürgen; Kneidinger, Nikolaus (2020)
  Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction
  In: Journal of heart and lung transplantation, Vol. 39, Nr. 11: S. 1270-1278
  
• Klemme, M.; Staffler, A.; Maio, N. de; Lauseker, Michael; Schubert, S.; Innocenti, P.; Wurster, T. M.; Foerster, K.; Herber-Jonat, S.; Mittal, R.; Messner, H.; Flemmer, A. W. (2020)
  Use of impregnated catheters to decrease colonization rates in neonates - a randomized controlled pilot trial
  In: Journal of Neonatal-Perinatal Medicine, Vol. 13, Nr. 2: S. 231-37
  
• Wolf, Sebastian; Lauseker, Michael; Schiergens, Tobias S.; Wirth, Ulrich; Drefs, Moritz; Renz, Bernhard; Ryll, Martin; Bucher, Julian; Werner, Jens; Guba, Markus; Andrassy, Joachim (2020)
  Infections after kidney transplantation: A comparison of mTOR-Is and CNIs as basic immunosuppressants. A systematic review and meta-analysis
  In: Transplant infectious disease: an official journal of the Transplantation Society, Vol. 22, Nr. 3 (Volltext vorhanden)
  
• Hehlmann, Rüdiger; Voskanyan, Astghik; Lauseker, Michael; Pfirrmann, Markus; Hasford, Jörg; Kolb, Hans-Jochem (2020)
  High-risk additional chromosomal abnormalities at low blast counts herald death by CML
  In: Leukemia, Vol. 34: S. 2074-2086 (Volltext vorhanden)
  
• Wolf, Sebastian; Lauseker, Michael; Schiergens, Tobias S.; Wirth, Ulrich; Drefs, Moritz; Renz, Bernhard; Ryll, Martin; Bucher, Julian; Werner, Jens; Guba, Markus; Andrassy, Joachim (2020)
  Infections after kidney transplantation: A comparison of mTOR‐Is and CNIs as basic immunosuppressants. A systematic review and meta‐analysis
  In: Transplant Infectious Disease, Vol. 22, Nr. 3 (Volltext vorhanden)
  
• Laubender, Ruediger P.; Mansmann, Ulrich; Lauseker, Michael (2020)
  Estimating the distribution of heterogeneous treatment effects from treatment responses and from a predictive biomarker in a parallel‐group RCT: A structural model approach
  In: Biometrical Journal, Vol. 62, Nr. 3: S. 697-711 (Volltext vorhanden)
  
• Pfirrmann, Markus; Clark, Richard E.; Prejzner, Witold; Lauseker, Michael; Baccarani, Michele; Saussele, Susanne; Guilhot, François; Hasford, Joerg; Hochhaus, Andreas; Hoffmann, Verena S. (2020)
  The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia
  In: Leukemia, Vol. 34, Nr. 8: S. 2138-2149 (Volltext vorhanden)
  
• Kaufmann, Elisabeth; Seethaler, Magdalena; Lauseker, Michael; Fan, Min; Vollmar, Christian; Noachtar, Soheyl; Rémi, Jan (2020)
  Who seizes longest? Impact of clinical and demographic factors
  In: Epilepsia, Vol. 61, Nr. 7: S. 1376-1385 (Volltext vorhanden)
  
• Hehlmann, Rüdiger; Voskanyan, Astghik; Lauseker, Michael; Pfirrmann, Markus (2020)
  Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML
  In: Leukemia, Vol. 34, Nr. 10
  
• Seethaler, Magdalena; Lauseker, Michael; Ernst, Katharina; Rémi, Jan; Vollmar, Christian; Noachtar, Soheyl; Kaufmann, Elisabeth (2020)
  Hemispheric differences in the duration of focal onset seizures
  In: Acta neurologica Scandinavica, Vol. 143, Nr. 3: S. 248-255 (Volltext vorhanden)
  
• Lauseker, Michael; Bachl, Katharina; Turkina, Anna; Faber, Edgar; Prejzner, Witold; Olsson-Strömberg, Ulla; Baccarani, Michele; Lomaia, Elza; Zackova, Daniela; Ossenkoppele, Gert; Griskevicius, Laimonas; Schubert-Fritschle, Gabriele; Sacha, Tomasz; Heibl, Sonja; Koskenvesa, Perttu; Bogdanovic, Andrija; Clark, Richard E.; Guilhot, Joelle; Hoffmann, Verena S.; Hasford, Joerg; Hochhaus, Andreas; Pfirrmann, Markus (2019)
  Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin
  In: American Journal of Hematology, Vol. 94, Nr. 11: S. 1236-1243 (Volltext vorhanden)
  
• Lauseker, Michael; Gerlach, Roman; Worseg, Wenke; Haferlach, Torsten; Tauscher, Martin; Hasford, Joerg; Hoffmann, Verena S. (2019)
  Differences in treatment and monitoring of chronic myeloid leukemia with regard to age, but not sex: Results from a population-based study
  In: European Journal of Haematology, Vol. 103, Nr. 4: S. 362-369 (Volltext vorhanden)
  
• Schroeder, Thomas; Wegener, Nadija; Lauseker, Michael; Rautenberg, Christina; Nachtkamp, Kathrin; Schuler, Esther; Kondakci, Mustafa; Haas, Rainer; Germing, Ulrich; Kobbe, Guido (2019)
  Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia
  In: Biology of Blood and Marrow Transplantation, Vol. 25, Nr. 8: S. 1550-1559
  
• Hartl, E.; Seethaler, M.; Lauseker, Michael; Rémi, J.; Vollmar, C.; Noachtar, S. (2019)
  Impact of withdrawal of antiepileptic medication on the duration of focal onset seizures
  In: Seizure-European Journal of Epilepsy, Vol. 67: S. 40-44
  
• Fankhauser, Maria; Bechmann, Nicole; Lauseker, Michael; Goncalves, Judith; Favier, Judith; Klink, Barbara; William, Doreen; Gieldon, Laura; Maurer, Julian; Spöttl, Gerald; Rank, Petra; Knösel, Thomas; Orth, Michael; Ziegler, Christian G.; Aristizabal Prada, Elke Tatjana; Rubinstein, German; Fassnacht, Martin; Spitzweg, Christine; Grossman, Ashley B.; Pacak, Karel; Beuschlein, Felix; Bornstein, Stefan R.; Eisenhofer, Graeme; Auernhammer, Christoph J.; Reincke, Martin; Nölting, Svenja (2019)
  Synergistic Highly Potent Targeted Drug Combinations in different Pheochromocytoma Models including Human Tumor Cultures
  In: Endocrinology, Vol. 160, Nr. 11: S. 2600-2617
  
• Lauseker, Michael; Eulenburg, Christine zu (2019)
  Analysis of cause of death: Competing risks or progressive illness-death model?
  In: Biometrical Journal, Vol. 61, Nr. 2: S. 264-274
  
• Michel, Christian; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Neubauer, Andreas; Lauseker, Michael; Krause, Stefan W.; Kolb, Hans-Jochem; Hossfeld, Dieter Kurt; Nerl, Christoph; Baerlocher, Gabriela M.; Heim, Dominik; Brümmendorf, Alice and Haferlach; Pfirrmann, Markus (2019)
  Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
  In: Haematologica, Vol. 104, Nr. 5: S. 955-962
  
• Aristizabal Prada, Elke Tatjana; Weis, Carla; Orth, Michael; Lauseker, Michael; Spöttl, Gerald; Maurer, Julian; Grabowski, Patricia; Grossman, Ashley; Auernhammer, Christoph Josef; Nölting, Svenja (2018)
  GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors?
  In: Neuroendocrinology, Vol. 106, Nr. 4: S. 335-351
  
• Andrassy, Joachim; Wolf, S.; Lauseker, Michael; Angele, Martin K.; van Rosmalen, M. D.; Samuel, U.; Rogiers, X.; Werner, J.; Guba, Markus (2018)
  Higher Retransplantation rate following Extended Right Split-Liver Transplantation - an analysis from the Eurotransplant Liver follow-up Registry
  In: Liver Transplantation, Vol. 24, Nr. 1: S. 26-34
  
• Kühnemuth, Benjamin; Piseddu, Ignazio; Wiedemann, Gabriela M.; Lauseker, Michael; Kuhn, Christina; Hofmann, Simone; Schmoeckel, Elisa; Endres, Stefan; Mayr, Doris; Jeschke, Udo; Anz, David (2018)
  CCL1 is a major regulatory T cell attracting factor in human breast cancer
  In: BMC Cancer (Volltext vorhanden)
  
• Schönberg, Markus Bo; Anger, Hubertus Johann Wolfgang; Hao, Jingcheng; Vater, Adrian; Bucher, Julian Nikolaus; Thomas, Michael Nikolaus; Lauseker, Michael; Rentsch, Markus; Schiergens, Tobias S.; Angele, Martin Kurt; Bazhin, Alexandr V.; Werner, Jens; Guba, Markus Otto (2018)
  Development of novel biological resection criteria for safe and oncologically satisfying resection of hepatocellular carcinoma
  In: Surgical Oncology, Vol. 27, Nr. 4: S. 663-673
  
• Saussele, Susanne; Hehlmann, Rüdiger; Fabarius, Alice; Jeromin, Sabine; Proetel, Ulrike; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Einsele, Hermann; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Oppliger Leibundgut, Elisabeth; Heim, Dominik; Krause, Stefan W.; Hofmann, Wolf-Karsten; Hasford, Joerg; Pfirrmann, Markus; Müller, Martin C.; Hochhaus, Andreas; Lauseker, Michael (2018)
  Defining therapy goals for major molecular remission in chronic myeloid leukemia: Results of the randomized CML Study IV
  In: Leukemia, Vol. 32, Nr. 5: S. 1222-1228 (Volltext vorhanden)
  
• Kuendgen, Andrea; Müller-Thomas, Catharina; Lauseker, Michael; Haferlach, Torsten; Urbaniak, Petra; Schroeder, Thomas; Brings, Carolin; Wulfert, Michael; Meggendorfer, Manja; Hildebrandt, Barbara; Betz, Beate; Royer-Pokora, Brigitte; Gattermann, Norbert; Haas, Rainer; Germing, Ulrich; Götze, Katharina S. (2018)
  Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature
  In: Oncotarget, Vol. 9, Nr. 45: S. 27882-27894
  
• Kaivers, J.; Lauseker, Michael; Hildebrandt, B.; Fenaux, P.; Pfeilstöcker, M.; Valent, P.; Platzbecker, U.; Latagliata, R.; Oliva, E. N.; Xicoy, B.; Götze, K.; Ganster, C.; Haase, D.; Bug, G.; Kündgen, A.; Gattermann, N.; Haas, R.; Germing, U. (2018)
  The IPSS-R has prognostic impact in untreated patients with MDS del(5q)
  In: Leukemia Research, Vol. 72: S. 27-33
  
• Aristizabal Prada, Elke Tatjana; Spöttl, Gerald; Maurer, Julian; Lauseker, Michael; Koziolek, Eva Jolanthe; Schrader, Jörg; Grossman, Ashley; Pacak, Karel; Beuschlein, Felix; Auernhammer, Christoph Joseph; Nölting, Svenja (2018)
  The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance
  In: Endocrine-Related Cancer, Vol. 25, Nr. 10: S. 893-908
  
• Lauseker, Michael; Hasford, Joerg; Saussele, Susanne; Kremers, Stephan; Kraemer, Doris; Lindemann, Walter; Hehlmann, Rüdiger; Pfirrmann, Markus (2017)
  Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death
  In: Cancer, Vol. 123, Nr. 13: S. 2467-2471
  
• Nölting, Svenja; Rentsch, Jakob; Freitag, Helma; Detjen, Katharina; Briest, Franziska; Möbs, Markus; Weissmann, Victoria; Siegmund, Britta; Auernhammer, Christoph J.; Prada, Elke Tatjana Aristizabal; Lauseker, Michael; Grossman, Ashley; Exner, Samantha; Fischer, Christian; Schrader, Jörg; Grabowski, Patricia (2017)
  The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models
  In: PLoS ONE, Vol. 12, Nr. 8 (Volltext vorhanden)
  
• Neukirchen, Judith; Lauseker, Michael; Hildebrandt, Barbara; Nolting, Ann-Christin; Kaivers, Jennifer; Kobbe, Guido; Gattermann, Norbert; Haas, Rainer; Germing, Ulrich (2017)
  Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis
  In: Cancer
  
• Andrassy, Joachim; Wolf, Sebastian; Lauseker, Michael; Angele, Martin; Samuel, Undine; Rogiers, Xavier; Werner, Jens; Guba, Markus (2017)
  Shipping Of Split-Livers Results in A Higher Retransplantation Rate But Does Not Affect Overall Patient's Survival: An Analysis from the Eurotransplant Liver Follow-Up Registry
  In: Transplant international, Vol. 30: S. 105-105
  
• Hehlmann, Rüdiger; Lauseker, Michael; Saußele, Susanne; Hochhaus, Andreas; Hasford, Joerg; Pfirrmann, Markus; Kolb, Hans-Jochem; Spiekermann, Karsten; Fabarius, Alice; Müller, M. C.; Proetel, Ulrike; Kohlbrenner, K.; Voskanyan, A.; Rinaldetti, S.; Seifarth, W.; Spieß, B.; Krause, S. W.; Neubauer, A.; Burchert, A.; Hossfeld, Dieter K.; Schafhausen, P.; Nerl, C.; Gratwohl, A.; Heim, D.; Baerlocher, Gabriela M.; Brümmendorf, Tim H.; Fuchs, R.; Haferlach, C.; Jeromin, S.; Schlegelberger, Brigitte; Balleisen, L.; Goebeler, M. C.; Hänel, M.; Ho, A.; Dengler, J.; Falge, C.; Kanz, L.; Kremers, S.; Kneba, M.; Stegelmann, F.; Köhne, C. A.; Lindemann, H. W.; Waller, C. F.; Pfreundschuh, Michael; Berdel, Wolfgang E.; Müller, L.; Edinger, M.; Mayer, J.; Beelen, D. W.; Bentz, M.; Link, H.; Hertenstein, Bernd; Wernli, Martin; Schlegel, F.; Schlag, R.; Wit, M. de; Trumper, L.; Hebart, H.; Hahn, M.; Thomalla, J.; Scheid, C.; Verbeek, W.; Eckart, M. J.; Gassmann, W.; Pezzutto, A.; Schenk, M.; Brossart, P.; Geer, T.; Bildat, S.; Schäfer, E. (2017)
  Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
  In: Leukemia, Vol. 31, Nr. 11: S. 2398-2406
  
• Miranda, M. B.; Lauseker, Michael; Kraus, M. P.; Proetel, U.; Hanfstein, B.; Fabarius, A.; Baerlocher, Gabriela M.; Heim, D.; Hossfeld, D. K.; Kolb, H. J.; Krause, S. W.; Nerl, C.; Brümmendorf, Tim H.; Verbeek, W.; Fauser, A. A.; Prummer, O.; Neben, K.; Hess, U.; Mahlberg, R.; Ploger, C.; Flasshove, M.; Rendenbach, B.; Hofmann, W. K.; Muller, M. C.; Pfirrmann, Markus; Hochhaus, A.; Hasford, Joerg; Hehlmann, R.; Saußele, Susanne (2016)
  Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
  In: Leukemia, Vol. 30, Nr. 6: S. 1255-1262
  
• Lauseker, Michael; Gerlach, R.; Tauscher, M.; Hasford, Joerg (2016)
  Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study
  In: Journal of Cancer Research and Clinical Oncology, Vol. 142, Nr. 7: S. 1441-1447
  
• Fabarius, A.; Kalmanti, L.; Dietz, C. T.; Lauseker, Michael; Rinaldetti, S.; Haferlach, C.; Göhring, G.; Schlegelberger, B.; Jotterand, M.; Hanfstein, B.; Seifarth, W.; Hänel, M.; Köhne, C. H.; Lindemann, H. W.; Berdel, W. E.; Staib, P.; Müller, M. C.; Proetel, U.; Balleisen, L.; Goebeler, M. E.; Dengler, J.; Falge, C.; Kanz, L.; Burchert, A.; Kneba, M.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, Karsten; Brümmendorf, Tim H.; Edinger, M.; Hofmann, W. K.; Pfirrmann, Markus; Hasford, Joerg; Krause, S.; Hochhaus, A.; Saußele, Susanne; Hehlmann, R. (2015)
  Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML
  In: Annals of Hematology, Vol. 94, Nr. 12: S. 2015-2024
  
• Kalmanti, L.; Saußele, Susanne; Lauseker, Michael; Muller, M. C.; Dietz, C. T.; Heinrich, L.; Hanfstein, B.; Proetel, U.; Fabarius, A.; Krause, S. W.; Rinaldetti, S.; Dengler, J.; Falge, C.; Oppliger-Leibundgut, E.; Burchert, A.; Neubauer, A.; Kanz, L.; Stegelmann, F.; Pfreundschuh, M.; Spiekermann, Karsten; Scheid, C.; Pfirrmann, Markus; Hochhaus, A.; Hasford, Joerg; Hehlmann, R. (2015)
  Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV
  In: Leukemia, Vol. 29, Nr. 5: S. 1123-1132
  
• Saußele, Susanne; Krauß, M. P.; Hehlmann, R.; Lauseker, Michael; Proetel, U.; Kalmanti, L.; Hanfstein, B.; Fabarius, A.; Kraemer, D.; Berdel, W. E.; Bentz, M.; Staib, P.; de Wit, M.; Wernli, M.; Zettl, F.; Hebart, H. F.; Hahn, M.; Heymanns, J.; Schmidt-Wolf, I.; Schmitz, N.; Eckart, M. J.; Gassmann, W.; Bartholomäus, A.; Pezzutto, A.; Oppliger Leibundgut, E.; Heim, D.; Krause, S. W.; Burchert, A.; Hofmann, W. K.; Hasford, Joerg; Hochhaus, A.; Pfirrmann, Markus; Müller, M. C. (2015)
  Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV
  In: Blood, Vol. 126, Nr. 1: S. 42-49
  
• Lauseker, Michael; Schemenau, J.; Strupp, C.; Kundgen, A.; Gattermann, N.; Hasford, Joerg; Germing, U. (2015)
  In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over time
  In: British Journal of Haematology, Vol. 170, Nr. 5: S. 687-693
  
• Lauseker, Michael; Hasford, Joerg; Hoffmann, V. S.; Mueller, M. C.; Hehlmann, R.; Pfirrmann, Markus (2015)
  A multi-state model approach for prediction in chronic myeloid leukaemia
  In: Annals of Hematology, Vol. 94, Nr. 6: S. 919-927
  
• Lauseker, Michael (2015)
  Reflections on the true nature of spatial clusters in myelodysplastic syndromes
  In: Leukemia & Lymphoma: S. 1-2
  
• Oliva, Esther N.; Lauseker, Michael; Spiriti, Maria Antonietta Aloe; Poloni, Antonella; Cortelezzi, Agostino; Palumbo, Giuseppe A.; Balleari, Enrico; Sanpaolo, Grazia; Volpe, Antonio; Ricco, Alessandra; Ronco, Francesca; Alati, Caterina; D'Errigo, Maria Grazia; Santacaterina, Irene; Kuendgen, Andrea; Germing, Ulrich; Latagliata, Roberto (2015)
  Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence
  In: Cancer Medicine, Vol. 4, Nr. 12: S. 1789-1797 (Volltext vorhanden)
  
• Pfirrmann, Markus; Lauseker, Michael; Hoffmann, V. S.; Hasford, Joerg (2015)
  Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death
  In: Annals of Hematology / Supplements, Vol. 94, Nr. 2: S. S209-18
  
• Lauseker, Michael; Hanfstein, Benjamin; Haferlach, Claudia; Schnittger, Susanne; Pfirrmann, Markus; Fabarius, Alice; Schlegelberger, Brigitte; Saußele, Susanne; Dietz, Christian T.; Erben, Philipp; Hehlmann, Rüdiger; Hasford, Joerg; Hochhaus, Andreas; Müller, Martin C. (2014)
  Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase
  In: Journal of cancer research and clinical oncology, Vol. 140, Nr. 11: S. 1965-1969
  
• Hanfstein, B.; Shlyakhto, V.; Lauseker, Michael; Hehlmann, R.; Saussele, S.; Dietz, C. T.; Erben, P.; Fabarius, A.; Proetel, U.; Schnittger, S.; Krause, S. W.; Schubert, J.; Einsele, H.; Hänel, M.; Dengler, J.; Falge, C.; Kanz, L.; Neubauer, A.; Kneba, M.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, K.; Baerlocher, G. M.; Pfirrmann, Markus; Hasford, Joerg; Hofmann, W. K.; Hochhaus, A.; Muller, M. C. (2014)
  Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib.
  In: Leukemia, Vol. 28, Nr. 10: S. 1988-1992
  
• Hehlmann, Rüdiger; Hasford, Joerg; Pfirrmann, Markus; Lauseker, Michael; Saußele, Susanne; Hochhaus, Andreas (2014)
  Reply to H. Kantarjian et al.
  In: Journal of Clinical Oncology, Vol. 32, Nr. 27
  
• Nölting, Svenja; Giubellino, Alessio; Tayem, Yasin; Young, Karen; Lauseker, Michael; Bullova, Petra; Schovanek, Jan; Anver, Miriam; Fliedner, Stephanie; Korbonits, Marta; Göke, Burkhard; Vlotides, George; Grossman, Ashley; Pacak, Karel (2014)
  Combination of 13-Cis Retinoic Acid and Lovastatin: Marked Antitumor Potential In Vivo in a Pheochromocytoma Allograft Model in Female Athymic Nude Mice
  In: Endocrinology, Vol. 155, Nr. 7: S. 2377-2390
  
• Proetel, Ulrike; Pletsch, Nadine; Lauseker, Michael; Müller, Martin C.; Hanfstein, Benjamin; Krause, Stefan W.; Kalmanti, Lida; Schreiber, Annette; Heim, Dominik; Baerlocher, Gabriela M.; Hofmann, Wolf-Karsten; Lange, Elisabeth; Einsele, Hermann; Wernli, Martin; Kremers, Stephan; Schlag, Rudolf; Müller, Lothar; Hänel, Mathias; Link, Hartmut; Hertenstein, Bernd; Pfirrmann, Markus; Hochhaus, Andreas; Hasford, Joerg; Hehlmann, Rüdiger; Saußele, Susanne (2014)
  Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV
  In: Annals of Hematology, Vol. 93, Nr. 7: S. 1167-1176 (Volltext vorhanden)
  
• Lauseker, Michael; Hasford, Joerg; Pfirrmann, Markus; Hehlmann, Rüdiger (2014)
  The impact of health care settings on survival time of patients with chronic myeloid leukemia
  In: Blood, Vol. 123, Nr. 16: S. 2494-2496
  
• Strobel, H.; Lauseker, Michael; Forbes, A. B. (2014)
  Targeted antibiotic treatment of lame sheep with footrot using either oxytetracycline or gamithromycin
  In: Veterinary Record, Vol. 147, Nr. 2: S. 46-46
  
• Neukirchen, J.; Lauseker, Michael; Blum, S.; Giagounidis, A.; Lubbert, M.; Martino, S.; Siragusa, S.; Schlenk, R. F.; Platzbecker, U.; Hofmann, W. K.; Gotze, K.; Palumbo, G. A.; Magrin, S.; Kundgen, A.; Aul, C.; Hildebrandt, B.; Hasford, Joerg; Kobbe, G.; Haas, R.; Germing, U. (2014)
  Validation of the revised International Prognostic Scoring System (IPSS-R) in patients with myelodysplastic syndrome: A multicenter study
  In: Leukemia Research, Vol. 38, Nr. 1: S. 57-64
  
• Kalmanti, L.; Saußele, Susanne; Lauseker, Michael; Proetel, U.; Muller, M. C.; Hanfstein, B.; Schreiber, A.; Fabarius, A.; Pfirrmann, Markus; Schnittger, S.; Dengler, J.; Falge, C.; Kanz, L.; Neubauer, A.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, Karsten; Krause, S. W.; Heim, D.; Nerl, C.; Hossfeld, D. K.; Kolb, H. J.; Hochhaus, A.; Hasford, Joerg; Hehlmann, R. (2014)
  Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV
  In: Annals of Hematology, Vol. 93, Nr. 1: S. 71-80
  
• Hehlmann, R.; Müller, M. C.; Lauseker, Michael; Hanfstein, B.; Fabarius, A.; Schreiber, A.; Proetel, U.; Pletsch, N.; Pfirrmann, Markus; Haferlach, C.; Schnittger, S.; Einsele, H.; Dengler, J.; Falge, C.; Kanz, L.; Neubauer, A.; Kneba, M.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Ehninger, G.; Heim, D.; Heimpel, H.; Nerl, C.; Krause, S. W.; Hossfeld, D. K.; Kolb, H. J.; Hasford, Joerg; Saußele, Susanne; Hochhaus, A. (2014)
  Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV
  In: Journal of Clinical Oncology, Vol. 32, Nr. 5: S. 415-423
  
• Hanfstein, Benjamin; Lauseker, Michael; Hehlmann, Rüdiger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fabarius, Alice; Proetel, Ulrike; Schnittger, Susanne; Haferlach, Claudia; Krause, Stefan W.; Schubert, Joerg; Einsele, Hermann; Hänel, Mathias; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Pfirrmann, Markus; Hasford, Jörg; Hofmann, Wolf-Karsten; Hochhaus, Andreas; Müller, Martin C. (2014)
  Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib
  In: Haematologica, Vol. 99, Nr. 9: S. 1441-1447 (Volltext vorhanden)
  
• Lauseker, Michael; Hasford, Joerg (2014)
  Remission status should not be treated as a base-line covariate – Reply to Etienne et al.
  In: Haematologica, Vol. 99, Nr. 9
  
• Kuendgen, A.; Lauseker, Michael; List, A. F.; Fenaux, P.; Giagounidis, A. A.; Brandenburg, N. A.; Backstrom, J.; Glasmacher, A.; Hasford, Joerg; Germing, U. (2013)
  Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis
  In: Leukemia, Vol. 27, Nr. 5: S. 1072-1079
  
• Lauseker, Michael; Pfirrmann, Markus; Hoffmann, V. S.; Hasford, Joerg (2012)
  Comment On “Second-Generation Tyrosine Kinase Inhibitors Improve The Survival Of Patients With Chronic Myeloid Leukemia In Whom Imatinib Therapy Has Failed” Haematologica 2011;96(12):1779–82
  In: Haematologica, Vol. 97, Nr. 5
  
• Germing, U.; Lauseker, Michael; Hildebrandt, B.; Symeonidis, A.; Cermak, J.; Fenaux, P.; Kelaidi, C.; Pfeilstöcker, M.; Nösslinger, T.; Sekeres, M.; Maciejewski, J.; Haase, D.; Schanz, J.; Seymour, J.; Kenealy, M.; Weide, R.; Lübbert, M.; Platzbecker, U.; Valent, P.; Götze, K.; Stauder, R.; Blum, S.; Kreuzer, K. A.; Schlenk, R.; Ganser, A.; Hofmann, W. K.; Aul, C.; Krieger, O.; Kundgen, A.; Haas, R.; Hasford, Joerg; Giagounidis, A. (2012)
  Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study
  In: Leukemia, Vol. 26, Nr. 6: S. 1286-1292
  
• Hanfstein, B.; Müller, M. C.; Hehlmann, R.; Erben, P.; Lauseker, Michael; Fabarius, A.; Schnittger, S.; Haferlach, C.; Göhring, G.; Proetel, U.; Kolb, H. J.; Krause, S. W.; Hofmann, W. K.; Schubert, J.; Einsele, H.; Dengler, J.; Hänel, M.; Falge, C.; Kanz, L.; Neubauer, A.; Kneba, M.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Branford, S.; Hughes, T. P.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Pfirrmann, Markus; Hasford, Joerg; Saußele, Susanne; Hochhaus, A. (2012)
  Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
  In: Leukemia, Vol. 26, Nr. 9: S. 2096-2102
  
• Nölting, Svenja; Kuttner, Axel; Lauseker, Michael; Vogeser, Michael; Haug, Alexander; Herrmann, Karin A.; Hoffmann, Johannes N.; Spitzweg, Christine; Göke, Burkhard; Auernhammer, Christoph J. (2012)
  Chromogranin A as serum marker for gastroenteropancreatic neuroendocrine tumors: a single center experience and literature review.
  In: Cancers, Vol. 4, Nr. 1: S. 141-155 (Volltext vorhanden)
  
• Fabarius, A.; Leitner, A.; Hochhaus, A.; Müller, M. C.; Hanfstein, B.; Haferlach, C.; Göhring, G.; Schlegelberger, B.; Jotterand, M.; Reiter, A.; Jung-Munkwitz, S.; Proetel, U.; Schwaab, J.; Hofmann, W. K.; Schubert, J.; Einsele, H.; Ho, A. D.; Falge, C.; Kanz, L.; Neubauer, A.; Kneba, M.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Lauseker, Michael; Pfirrmann, Markus; Hasford, Joerg; Saußele, Susanne; Hehlmann, R. (2011)
  Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: Long-term observation of 1151 patients from the randomized CML Study IV
  In: Blood, Vol. 118, Nr. 26: S. 6760-6768
  
• Hehlmann, R.; Lauseker, Michael; Jung-Munkwitz, S.; Leitner, A.; Müller, M. C.; Pletsch, N.; Proetel, U.; Haferlach, C.; Schlegelberger, B.; Balleisen, L.; Hänel, M.; Pfirrmann, Markus; Krause, S. W.; Nerl, C.; Pralle, H.; Gratwohl, A.; Hossfeld, D. K.; Hasford, Joerg; Hochhaus, A.; Saußele, Susanne (2011)
  Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-alpha in newly diagnosed chronic myeloid leukemia
  In: Journal of Clinical Oncology, Vol. 29, Nr. 12: S. 1634-1642
  
• Pfirrmann, Markus; Hochhaus, A.; Lauseker, Michael; Saußele, Susanne; Hehlmann, R.; Hasford, Joerg (2011)
  Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia
  In: Leukemia, Vol. 25, Nr. 9: S. 1433-1438
  
• Saußele, Susanne; Lauseker, Michael; Gratwohl, A.; Beelen, D. W.; Bunjes, D.; Schwerdtfeger, R.; Kolb, H. J.; Ho, A. D.; Falge, C.; Holler, E.; Schlimok, G.; Zander, A. R.; Arnold, R.; Kanz, L.; Dengler, R.; Haferlach, C.; Schlegelberger, B.; Pfirrmann, Markus; Müller, M. C.; Schnittger, S.; Leitner, A.; Pletsch, N.; Hochhaus, A.; Hasford, Joerg; Hehlmann, R. (2010)
  Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV
  In: Blood, Vol. 115, Nr. 10: S. 1880-1885